Efficacy and Safety of Ketorolac for Pain Management After Congenital Heart Surgery: A Comparison to Paracetamol
Archives of Critical Care Medicine,
Vol. 1 No. 4 (2016),
28 October 2023
Abstract
Background: Pain is an unpleasant complication commonly observed following congenital heart surgery, but is not often treated properly. Objectives: The current study aimed to investigate the efficacy and safety of ketorolac to manage postoperative pain after pediatric heart surgery.
Methods: Eighty-one pediatric patients undergoing cardiac surgery received either ketorolac 0.5 mg/kg or paracetamol 15 mg/kg for postoperative pain control every six and eight hours on the first and second postoperative days, respectively. The critical-care pain observation tool (CPOT) and the face, legs, activity, cry, consolability (FLACC) scale were employed to investigate the pain severity. The patients were also investigated for additional analgesic requirements, and associated complications including acute kidney injury, gastrointestinal discomfort and bleeding in patients.
Results: Patients in the ketorolac group experienced less pain than the ones in the paracetamol group. More fentanyl was required for pain relief in the paracetamol than the ketorolac group. Use of ketorolac was not associated with more adverse effects in com[1]parison to paracetamol.
Conclusions: Ketorolac is safe and effective to manage postoperative pain after congenital heart surgery. It is more effective than paracetamol for pain relief and requires less additional rescue analgesic.
- Paracetamol
- Ketorolac
- Congenital Heart Surgery
How to Cite
References
Bruce EA, Howard RF, Franck LS. Chest drain removal pain and its
management: a literature review. J Clin Nurs. 2006;15(2):145–54. doi:
1111/j.1365-2702.2006.01273.x. [PubMed: 16422731].
Foruzannia K, Moshtaghiun H, Mirhosseini H, Abdolahi.M H, Golzar A.
Comparative effects of tramadol, indomethacin, and acetaminophen
in controlling pain after coronary artery bypass surgery. Anaesthesiol
Intens Care J. 2009;30(61):32–40.
Baley K, Michalov K, Kossick MA, McDowell M. Intravenous acetaminophen and intravenous ketorolac for management of pediatric surgical pain: a literature review. AANA J. 2014;82(1):53–64.
[PubMed: 24654353].
Richardson MD, Palmeri NO, Williams SA, Torok MR, O’Neill BR, Handler MH, et al. Routine perioperative ketorolac administration is
not associated with hemorrhage in pediatric neurosurgery patients.
J Neurosurg Pediatr. 2016;17(1):107–15. doi: 10.3171/2015.4.PEDS14411.
[PubMed: 26451718].
Chan DK, Parikh SR. Perioperative ketorolac increases posttonsillectomy hemorrhage in adults but not children. Laryngoscope.
;124(8):1789–93. doi: 10.1002/lary.24555. [PubMed: 24338331].
Sukhtankar DD, Lee H, Rice KC, Ko MC. Differential effects of opioidrelated ligands and NSAIDs in nonhuman primate models of acute
and inflammatory pain. Psychopharmacology (Berl). 2014;231(7):1377–
doi: 10.1007/s00213-013-3341-0. [PubMed: 24217900].
Holdgate A, Asha S, Craig J, Thompson J. Comparison of a verbal
numeric rating scale with the visual analogue scale for the measurement of acute pain. Emerg Med (Fremantle). 2003;15(5-6):441–6.
[PubMed: 14992058].
Thagaard KS, Jensen HH, Raeder J. Analgesic and antiemetic effect
of ketorolac vs. betamethasone or dexamethasone after ambulatory
surgery. Acta Anaesthesiol Scand. 2007;51(3):271–7. doi: 10.1111/j.1399-
2006.01240.x. [PubMed: 17257175].
Jalkut MK. Ketorolac as an analgesic agent for infants and
children after cardiac surgery: safety profile and appropriate patient selection. AACN Adv Crit Care. 2014;25(1):23–30. doi:
1097/NCI.0000000000000002. [PubMed: 24441450].
Inoue M, Caldarone CA, Frndova H, Cox PN, Ito S, Taddio A, et al.
Safety and efficacy of ketorolac in children after cardiac surgery. Intensive Care Med. 2009;35(9):1584–92. doi: 10.1007/s00134-009-1541-1.
[PubMed: 19562323].
Dawkins TN, Barclay CA, Gardiner RL, Krawczeski CD. Safety of intravenous use of ketorolac in infants following cardiothoracic surgery.
Cardiol Young. 2009;19(1):105–8. doi: 10.1017/S1047951109003527.
[PubMed: 19134246].
Lee SY, Lee WH, Lee EH, Han KC, Ko YK. The effects of paracetamol, ketorolac, and paracetamol plus morphine on pain control after thyroidectomy. Korean J Pain. 2010;23(2):124–30. doi:
3344/kjp.2010.23.2.124. [PubMed: 20556214].
Anand A, Sprenker CJ, Karlnoski R, Norman J, Miladinovic B, Wilburn
B, et al. Intravenous acetaminophen vs. ketorolac for postoperative
analgesia after ambulatory parathyroidectomy. Scandinavian J Pain.
;4(4):249–53. doi: 10.1016/j.sjpain.2013.06.001.
Burd RS, Tobias JD. Ketorolac for pain management after abdominal surgical procedures in infants. South Med J. 2002;95(3):331–3.
[PubMed: 11902701].
Chauhan RD, Idom CB, Noe HN. Safety of ketorolac in the pediatric
population after ureteroneocystostomy. J Urol. 2001;166(5):1873–5.
[PubMed: 11586252].
Shekari M. The effect of paracetamol, morphine intravenously and intravenous ketorolac control of renal colic pain in patients presenting
to the emergency room [in Pesian]. Bandar abbas univ med sci. 2014.
Iorno V, Landi L, Di Pasquale R, Cicenia S, Moschini V. Comparison of intravenous ketorolac with or without paracetamol in postoperative pain control following ambulatory surgery. Curr Med
Res Opin. 2013;29(12):1685–90. doi: 10.1185/03007995.2013.835256.
[PubMed: 23998433].
Lynn AM, Bradford H, Kantor ED, Andrew M, Vicini P, Anderson
GD. Ketorolac tromethamine: stereo-specific pharmacokinetics and
single-dose use in postoperative infants aged 2-6 months. Paediatr Anaesth. 2011;21(3):325–34. doi: 10.1111/j.1460-9592.2010.03484.x.
[PubMed: 21199130].
Gupta A, Daggett C, Drant S, Rivero N, Lewis A. Prospective randomized trial of ketorolac after congenital heart surgery. J Cardiothorac
Vasc Anesth. 2004;18(4):454–7. [PubMed: 15365927].
Bosek V, Smith DB, Endicott J, Klotch D, Ridley M. Comparison of
intravenous ketorolac and alfentanil as supplements to propofol
anesthesia for diagnostic panendoscopy. J Clin Anesth. 1995;7(1):40–3.
[PubMed: 7503851].
Moffett BS, Cabrera A. Ketorolac-associated renal morbidity: risk factors in cardiac surgical infants. Cardiol Young. 2013;23(5):752–4. doi:
1017/S1047951112001680. [PubMed: 23088994].
Moffett BS, Wann TI, Carberry KE, Mott AR. Safety of ketorolac
in neonates and infants after cardiac surgery. Paediatr Anaesth.
;16(4):424–8. doi: 10.1111/j.1460-9592.2005.01806.x. [PubMed:
.
Gupta A, Daggett C, Ludwick J, Wells W, Lewis A. Ketorolac after congenital heart surgery: does it increase the risk of significant bleeding
complications?. Paediatr Anaesth. 2005;15(2):139–42. doi: 10.1111/j.1460-
2005.01409.x. [PubMed: 15675931].
- Abstract Viewed: 8 times
- PDF Downloaded: 0 times